Celldex Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Celldex Therapeutics, Inc. (CLDX) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $900.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-07.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2018-03-07
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $900.00K.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $900.00K.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
- 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2017-12-31 | $900.00K 10-K · filed 2018-03-07 |
| 2016-12-31 | $900.00K 10-K · filed 2017-03-14 |
| 2015-12-31 | $1.00M 10-K/A · filed 2016-02-25 |
| 2014-12-31 | $1.00M 10-K · filed 2015-02-24 |
| 2013-12-31 | $1.00M 10-K · filed 2014-03-03 |
| 2012-12-31 | $1.00M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |